Global Anti-Infectives Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Anti-Infectives market size is predicted to grow from US$ 23940 million in 2025 to US$ 27580 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infectives Industry Forecast” looks at past sales and reviews total world Anti-Infectives sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infectives sales for 2025 through 2031. With Anti-Infectives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infectives industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infectives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infectives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infectives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infectives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infectives.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infectives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-Infectives market?
What factors are driving Anti-Infectives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infectives market opportunities vary by end market size?
How does Anti-Infectives break out by Type, by Application?
The global Anti-Infectives market size is predicted to grow from US$ 23940 million in 2025 to US$ 27580 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Anti-Infectives Industry Forecast” looks at past sales and reviews total world Anti-Infectives sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-Infectives sales for 2025 through 2031. With Anti-Infectives sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Infectives industry.
This Insight Report provides a comprehensive analysis of the global Anti-Infectives landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-Infectives portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Infectives market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Infectives and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Infectives.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Infectives market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Antibacterial
- Antiviral
- Antifungal
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astra Zeneca plc
- Johnson & Johnson
- Glaxo SmithKline plc
- Novartis
- Pfizer
- Wockhardt ltd
- Roche
- Sanofi
- Merck
What is the 10-year outlook for the global Anti-Infectives market?
What factors are driving Anti-Infectives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-Infectives market opportunities vary by end market size?
How does Anti-Infectives break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infectives Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infectives by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infectives by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infectives Segment by Type
2.2.1 Antibacterial
2.2.2 Antiviral
2.2.3 Antifungal
2.3 Anti-Infectives Sales by Type
2.3.1 Global Anti-Infectives Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infectives Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infectives Sale Price by Type (2020-2025)
2.4 Anti-Infectives Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Mail Order Pharmacies
2.5 Anti-Infectives Sales by Application
2.5.1 Global Anti-Infectives Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infectives Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infectives Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infectives Breakdown Data by Company
3.1.1 Global Anti-Infectives Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infectives Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infectives Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infectives Revenue by Company (2020-2025)
3.2.2 Global Anti-Infectives Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infectives Sale Price by Company
3.4 Key Manufacturers Anti-Infectives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infectives Product Location Distribution
3.4.2 Players Anti-Infectives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVES BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infectives Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infectives Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infectives Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infectives Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infectives Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infectives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infectives Sales Growth
4.4 APAC Anti-Infectives Sales Growth
4.5 Europe Anti-Infectives Sales Growth
4.6 Middle East & Africa Anti-Infectives Sales Growth
5 AMERICAS
5.1 Americas Anti-Infectives Sales by Country
5.1.1 Americas Anti-Infectives Sales by Country (2020-2025)
5.1.2 Americas Anti-Infectives Revenue by Country (2020-2025)
5.2 Americas Anti-Infectives Sales by Type (2020-2025)
5.3 Americas Anti-Infectives Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infectives Sales by Region
6.1.1 APAC Anti-Infectives Sales by Region (2020-2025)
6.1.2 APAC Anti-Infectives Revenue by Region (2020-2025)
6.2 APAC Anti-Infectives Sales by Type (2020-2025)
6.3 APAC Anti-Infectives Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infectives by Country
7.1.1 Europe Anti-Infectives Sales by Country (2020-2025)
7.1.2 Europe Anti-Infectives Revenue by Country (2020-2025)
7.2 Europe Anti-Infectives Sales by Type (2020-2025)
7.3 Europe Anti-Infectives Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infectives by Country
8.1.1 Middle East & Africa Anti-Infectives Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infectives Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infectives Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infectives Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infectives
10.3 Manufacturing Process Analysis of Anti-Infectives
10.4 Industry Chain Structure of Anti-Infectives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infectives Distributors
11.3 Anti-Infectives Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVES BY GEOGRAPHIC REGION
12.1 Global Anti-Infectives Market Size Forecast by Region
12.1.1 Global Anti-Infectives Forecast by Region (2026-2031)
12.1.2 Global Anti-Infectives Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infectives Forecast by Type (2026-2031)
12.7 Global Anti-Infectives Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Astra Zeneca plc
13.1.1 Astra Zeneca plc Company Information
13.1.2 Astra Zeneca plc Anti-Infectives Product Portfolios and Specifications
13.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Astra Zeneca plc Main Business Overview
13.1.5 Astra Zeneca plc Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Anti-Infectives Product Portfolios and Specifications
13.2.3 Johnson & Johnson Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Glaxo SmithKline plc
13.3.1 Glaxo SmithKline plc Company Information
13.3.2 Glaxo SmithKline plc Anti-Infectives Product Portfolios and Specifications
13.3.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glaxo SmithKline plc Main Business Overview
13.3.5 Glaxo SmithKline plc Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Anti-Infectives Product Portfolios and Specifications
13.4.3 Novartis Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Anti-Infectives Product Portfolios and Specifications
13.5.3 Pfizer Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Wockhardt ltd
13.6.1 Wockhardt ltd Company Information
13.6.2 Wockhardt ltd Anti-Infectives Product Portfolios and Specifications
13.6.3 Wockhardt ltd Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Wockhardt ltd Main Business Overview
13.6.5 Wockhardt ltd Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Anti-Infectives Product Portfolios and Specifications
13.7.3 Roche Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Anti-Infectives Product Portfolios and Specifications
13.8.3 Sanofi Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Anti-Infectives Product Portfolios and Specifications
13.9.3 Merck Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-Infectives Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infectives Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Global Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 7. Global Anti-Infectives Sales Market Share byType (2020-2025)
Table 8. Global Anti-Infectives Revenue byType (2020-2025) & ($ million)
Table 9. Global Anti-Infectives Revenue Market Share byType (2020-2025)
Table 10. Global Anti-Infectives Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Anti-Infectives Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Infectives Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Infectives Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Infectives Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Infectives Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Infectives Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Infectives Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Infectives Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Infectives Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Infectives Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Infectives Producing Area Distribution and Sales Area
Table 22. Players Anti-Infectives Products Offered
Table 23. Anti-Infectives Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Infectives Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Infectives Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Infectives Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Infectives Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Infectives Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Infectives Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Infectives Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Infectives Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Infectives Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Infectives Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 38. Americas Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Infectives Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Infectives Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Infectives Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 43. APAC Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Infectives Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 47. Europe Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infectives Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Infectives
Table 53. Key Market Challenges & Risks of Anti-Infectives
Table 54. Key IndustryTrends of Anti-Infectives
Table 55. Anti-Infectives Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Infectives Distributors List
Table 58. Anti-Infectives Customer List
Table 59. Global Anti-Infectives SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Infectives RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Infectives Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Infectives SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Infectives Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Infectives RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Infectives RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Infectives SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Anti-Infectives RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Anti-Infectives SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Infectives RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Astra Zeneca plc Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 74. Astra Zeneca plc Anti-Infectives Product Portfolios and Specifications
Table 75. Astra Zeneca plc Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Astra Zeneca plc Main Business
Table 77. Astra Zeneca plc Latest Developments
Table 78. Johnson & Johnson Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Anti-Infectives Product Portfolios and Specifications
Table 80. Johnson & Johnson Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. Glaxo SmithKline plc Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 84. Glaxo SmithKline plc Anti-Infectives Product Portfolios and Specifications
Table 85. Glaxo SmithKline plc Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Glaxo SmithKline plc Main Business
Table 87. Glaxo SmithKline plc Latest Developments
Table 88. Novartis Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Anti-Infectives Product Portfolios and Specifications
Table 90. Novartis Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Anti-Infectives Product Portfolios and Specifications
Table 95. Pfizer Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Wockhardt ltd Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 99. Wockhardt ltd Anti-Infectives Product Portfolios and Specifications
Table 100. Wockhardt ltd Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Wockhardt ltd Main Business
Table 102. Wockhardt ltd Latest Developments
Table 103. Roche Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Anti-Infectives Product Portfolios and Specifications
Table 105. Roche Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Sanofi Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Anti-Infectives Product Portfolios and Specifications
Table 110. Sanofi Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Merck Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck Anti-Infectives Product Portfolios and Specifications
Table 115. Merck Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Merck Main Business
Table 117. Merck Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-Infectives
Figure 2. Anti-Infectives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infectives Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infectives Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infectives Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infectives Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infectives Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antibacterial
Figure 12. Product Picture of Antiviral
Figure 13. Product Picture of Antifungal
Figure 14. Global Anti-Infectives Sales Market Share byType in 2025
Figure 15. Global Anti-Infectives Revenue Market Share byType (2020-2025)
Figure 16. Anti-Infectives Consumed in Hospital Pharmacies
Figure 17. Global Anti-Infectives Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Anti-Infectives Consumed in Retail Pharmacies
Figure 19. Global Anti-Infectives Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Anti-Infectives Consumed in Mail Order Pharmacies
Figure 21. Global Anti-Infectives Market: Mail Order Pharmacies (2020-2025) & (K Units)
Figure 22. Global Anti-Infectives Sale Market Share by Application (2024)
Figure 23. Global Anti-Infectives Revenue Market Share by Application in 2025
Figure 24. Anti-Infectives Sales by Company in 2025 (K Units)
Figure 25. Global Anti-Infectives Sales Market Share by Company in 2025
Figure 26. Anti-Infectives Revenue by Company in 2025 ($ millions)
Figure 27. Global Anti-Infectives Revenue Market Share by Company in 2025
Figure 28. Global Anti-Infectives Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Anti-Infectives Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Anti-Infectives Sales 2020-2025 (K Units)
Figure 31. Americas Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 32. APAC Anti-Infectives Sales 2020-2025 (K Units)
Figure 33. APAC Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 34. Europe Anti-Infectives Sales 2020-2025 (K Units)
Figure 35. Europe Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Anti-Infectives Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 38. Americas Anti-Infectives Sales Market Share by Country in 2025
Figure 39. Americas Anti-Infectives Revenue Market Share by Country (2020-2025)
Figure 40. Americas Anti-Infectives Sales Market Share byType (2020-2025)
Figure 41. Americas Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 42. United States Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Anti-Infectives Sales Market Share by Region in 2025
Figure 47. APAC Anti-Infectives Revenue Market Share by Region (2020-2025)
Figure 48. APAC Anti-Infectives Sales Market Share byType (2020-2025)
Figure 49. APAC Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 50. China Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 54. India Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Anti-Infectives Sales Market Share by Country in 2025
Figure 58. Europe Anti-Infectives Revenue Market Share by Country (2020-2025)
Figure 59. Europe Anti-Infectives Sales Market Share byType (2020-2025)
Figure 60. Europe Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 61. Germany Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 62.France Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Anti-Infectives Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Anti-Infectives Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 69. Egypt Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Infectives in 2025
Figure 75. Manufacturing Process Analysis of Anti-Infectives
Figure 76. Industry Chain Structure of Anti-Infectives
Figure 77. Channels of Distribution
Figure 78. Global Anti-Infectives Sales MarketForecast by Region (2026-2031)
Figure 79. Global Anti-Infectives Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Anti-Infectives Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Anti-Infectives Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Anti-Infectives Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Anti-Infectives Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-Infectives Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Anti-Infectives by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Anti-Infectives by Country/Region, 2020, 2024 & 2031
2.2 Anti-Infectives Segment by Type
2.2.1 Antibacterial
2.2.2 Antiviral
2.2.3 Antifungal
2.3 Anti-Infectives Sales by Type
2.3.1 Global Anti-Infectives Sales Market Share by Type (2020-2025)
2.3.2 Global Anti-Infectives Revenue and Market Share by Type (2020-2025)
2.3.3 Global Anti-Infectives Sale Price by Type (2020-2025)
2.4 Anti-Infectives Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Mail Order Pharmacies
2.5 Anti-Infectives Sales by Application
2.5.1 Global Anti-Infectives Sale Market Share by Application (2020-2025)
2.5.2 Global Anti-Infectives Revenue and Market Share by Application (2020-2025)
2.5.3 Global Anti-Infectives Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Anti-Infectives Breakdown Data by Company
3.1.1 Global Anti-Infectives Annual Sales by Company (2020-2025)
3.1.2 Global Anti-Infectives Sales Market Share by Company (2020-2025)
3.2 Global Anti-Infectives Annual Revenue by Company (2020-2025)
3.2.1 Global Anti-Infectives Revenue by Company (2020-2025)
3.2.2 Global Anti-Infectives Revenue Market Share by Company (2020-2025)
3.3 Global Anti-Infectives Sale Price by Company
3.4 Key Manufacturers Anti-Infectives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Infectives Product Location Distribution
3.4.2 Players Anti-Infectives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-INFECTIVES BY GEOGRAPHIC REGION
4.1 World Historic Anti-Infectives Market Size by Geographic Region (2020-2025)
4.1.1 Global Anti-Infectives Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Anti-Infectives Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Anti-Infectives Market Size by Country/Region (2020-2025)
4.2.1 Global Anti-Infectives Annual Sales by Country/Region (2020-2025)
4.2.2 Global Anti-Infectives Annual Revenue by Country/Region (2020-2025)
4.3 Americas Anti-Infectives Sales Growth
4.4 APAC Anti-Infectives Sales Growth
4.5 Europe Anti-Infectives Sales Growth
4.6 Middle East & Africa Anti-Infectives Sales Growth
5 AMERICAS
5.1 Americas Anti-Infectives Sales by Country
5.1.1 Americas Anti-Infectives Sales by Country (2020-2025)
5.1.2 Americas Anti-Infectives Revenue by Country (2020-2025)
5.2 Americas Anti-Infectives Sales by Type (2020-2025)
5.3 Americas Anti-Infectives Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Infectives Sales by Region
6.1.1 APAC Anti-Infectives Sales by Region (2020-2025)
6.1.2 APAC Anti-Infectives Revenue by Region (2020-2025)
6.2 APAC Anti-Infectives Sales by Type (2020-2025)
6.3 APAC Anti-Infectives Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-Infectives by Country
7.1.1 Europe Anti-Infectives Sales by Country (2020-2025)
7.1.2 Europe Anti-Infectives Revenue by Country (2020-2025)
7.2 Europe Anti-Infectives Sales by Type (2020-2025)
7.3 Europe Anti-Infectives Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-Infectives by Country
8.1.1 Middle East & Africa Anti-Infectives Sales by Country (2020-2025)
8.1.2 Middle East & Africa Anti-Infectives Revenue by Country (2020-2025)
8.2 Middle East & Africa Anti-Infectives Sales by Type (2020-2025)
8.3 Middle East & Africa Anti-Infectives Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Infectives
10.3 Manufacturing Process Analysis of Anti-Infectives
10.4 Industry Chain Structure of Anti-Infectives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Infectives Distributors
11.3 Anti-Infectives Customer
12 WORLD FORECAST REVIEW FOR ANTI-INFECTIVES BY GEOGRAPHIC REGION
12.1 Global Anti-Infectives Market Size Forecast by Region
12.1.1 Global Anti-Infectives Forecast by Region (2026-2031)
12.1.2 Global Anti-Infectives Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Anti-Infectives Forecast by Type (2026-2031)
12.7 Global Anti-Infectives Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Astra Zeneca plc
13.1.1 Astra Zeneca plc Company Information
13.1.2 Astra Zeneca plc Anti-Infectives Product Portfolios and Specifications
13.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Astra Zeneca plc Main Business Overview
13.1.5 Astra Zeneca plc Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Anti-Infectives Product Portfolios and Specifications
13.2.3 Johnson & Johnson Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Glaxo SmithKline plc
13.3.1 Glaxo SmithKline plc Company Information
13.3.2 Glaxo SmithKline plc Anti-Infectives Product Portfolios and Specifications
13.3.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Glaxo SmithKline plc Main Business Overview
13.3.5 Glaxo SmithKline plc Latest Developments
13.4 Novartis
13.4.1 Novartis Company Information
13.4.2 Novartis Anti-Infectives Product Portfolios and Specifications
13.4.3 Novartis Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis Main Business Overview
13.4.5 Novartis Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Anti-Infectives Product Portfolios and Specifications
13.5.3 Pfizer Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Wockhardt ltd
13.6.1 Wockhardt ltd Company Information
13.6.2 Wockhardt ltd Anti-Infectives Product Portfolios and Specifications
13.6.3 Wockhardt ltd Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Wockhardt ltd Main Business Overview
13.6.5 Wockhardt ltd Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Anti-Infectives Product Portfolios and Specifications
13.7.3 Roche Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Anti-Infectives Product Portfolios and Specifications
13.8.3 Sanofi Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Anti-Infectives Product Portfolios and Specifications
13.9.3 Merck Anti-Infectives Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Anti-Infectives Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Anti-Infectives Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibacterial
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Global Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 7. Global Anti-Infectives Sales Market Share byType (2020-2025)
Table 8. Global Anti-Infectives Revenue byType (2020-2025) & ($ million)
Table 9. Global Anti-Infectives Revenue Market Share byType (2020-2025)
Table 10. Global Anti-Infectives Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Anti-Infectives Sale by Application (2020-2025) & (K Units)
Table 12. Global Anti-Infectives Sale Market Share by Application (2020-2025)
Table 13. Global Anti-Infectives Revenue by Application (2020-2025) & ($ million)
Table 14. Global Anti-Infectives Revenue Market Share by Application (2020-2025)
Table 15. Global Anti-Infectives Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Anti-Infectives Sales by Company (2020-2025) & (K Units)
Table 17. Global Anti-Infectives Sales Market Share by Company (2020-2025)
Table 18. Global Anti-Infectives Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Anti-Infectives Revenue Market Share by Company (2020-2025)
Table 20. Global Anti-Infectives Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Anti-Infectives Producing Area Distribution and Sales Area
Table 22. Players Anti-Infectives Products Offered
Table 23. Anti-Infectives Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Anti-Infectives Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Anti-Infectives Sales Market Share Geographic Region (2020-2025)
Table 28. Global Anti-Infectives Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Anti-Infectives Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Anti-Infectives Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Anti-Infectives Sales Market Share by Country/Region (2020-2025)
Table 32. Global Anti-Infectives Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Anti-Infectives Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 35. Americas Anti-Infectives Sales Market Share by Country (2020-2025)
Table 36. Americas Anti-Infectives Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 38. Americas Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 39. APAC Anti-Infectives Sales by Region (2020-2025) & (K Units)
Table 40. APAC Anti-Infectives Sales Market Share by Region (2020-2025)
Table 41. APAC Anti-Infectives Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 43. APAC Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 44. Europe Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 45. Europe Anti-Infectives Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 47. Europe Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Anti-Infectives Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Anti-Infectives Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Anti-Infectives Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Anti-Infectives Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Anti-Infectives
Table 53. Key Market Challenges & Risks of Anti-Infectives
Table 54. Key IndustryTrends of Anti-Infectives
Table 55. Anti-Infectives Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Anti-Infectives Distributors List
Table 58. Anti-Infectives Customer List
Table 59. Global Anti-Infectives SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Anti-Infectives RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Anti-Infectives Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Anti-Infectives SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Anti-Infectives Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Anti-Infectives RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Anti-Infectives SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Anti-Infectives RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Anti-Infectives SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Anti-Infectives RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Anti-Infectives SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Anti-Infectives RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Astra Zeneca plc Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 74. Astra Zeneca plc Anti-Infectives Product Portfolios and Specifications
Table 75. Astra Zeneca plc Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Astra Zeneca plc Main Business
Table 77. Astra Zeneca plc Latest Developments
Table 78. Johnson & Johnson Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 79. Johnson & Johnson Anti-Infectives Product Portfolios and Specifications
Table 80. Johnson & Johnson Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Main Business
Table 82. Johnson & Johnson Latest Developments
Table 83. Glaxo SmithKline plc Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 84. Glaxo SmithKline plc Anti-Infectives Product Portfolios and Specifications
Table 85. Glaxo SmithKline plc Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Glaxo SmithKline plc Main Business
Table 87. Glaxo SmithKline plc Latest Developments
Table 88. Novartis Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Anti-Infectives Product Portfolios and Specifications
Table 90. Novartis Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Anti-Infectives Product Portfolios and Specifications
Table 95. Pfizer Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Wockhardt ltd Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 99. Wockhardt ltd Anti-Infectives Product Portfolios and Specifications
Table 100. Wockhardt ltd Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Wockhardt ltd Main Business
Table 102. Wockhardt ltd Latest Developments
Table 103. Roche Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Anti-Infectives Product Portfolios and Specifications
Table 105. Roche Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Sanofi Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Anti-Infectives Product Portfolios and Specifications
Table 110. Sanofi Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Merck Basic Information, Anti-Infectives Manufacturing Base, Sales Area and Its Competitors
Table 114. Merck Anti-Infectives Product Portfolios and Specifications
Table 115. Merck Anti-Infectives Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Merck Main Business
Table 117. Merck Latest Developments
LIST OFFIGURES
Figure 1. Picture of Anti-Infectives
Figure 2. Anti-Infectives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-Infectives Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Anti-Infectives Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Anti-Infectives Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Anti-Infectives Sales Market Share by Country/Region (2024)
Figure 10. Anti-Infectives Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antibacterial
Figure 12. Product Picture of Antiviral
Figure 13. Product Picture of Antifungal
Figure 14. Global Anti-Infectives Sales Market Share byType in 2025
Figure 15. Global Anti-Infectives Revenue Market Share byType (2020-2025)
Figure 16. Anti-Infectives Consumed in Hospital Pharmacies
Figure 17. Global Anti-Infectives Market: Hospital Pharmacies (2020-2025) & (K Units)
Figure 18. Anti-Infectives Consumed in Retail Pharmacies
Figure 19. Global Anti-Infectives Market: Retail Pharmacies (2020-2025) & (K Units)
Figure 20. Anti-Infectives Consumed in Mail Order Pharmacies
Figure 21. Global Anti-Infectives Market: Mail Order Pharmacies (2020-2025) & (K Units)
Figure 22. Global Anti-Infectives Sale Market Share by Application (2024)
Figure 23. Global Anti-Infectives Revenue Market Share by Application in 2025
Figure 24. Anti-Infectives Sales by Company in 2025 (K Units)
Figure 25. Global Anti-Infectives Sales Market Share by Company in 2025
Figure 26. Anti-Infectives Revenue by Company in 2025 ($ millions)
Figure 27. Global Anti-Infectives Revenue Market Share by Company in 2025
Figure 28. Global Anti-Infectives Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Anti-Infectives Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Anti-Infectives Sales 2020-2025 (K Units)
Figure 31. Americas Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 32. APAC Anti-Infectives Sales 2020-2025 (K Units)
Figure 33. APAC Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 34. Europe Anti-Infectives Sales 2020-2025 (K Units)
Figure 35. Europe Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Anti-Infectives Sales 2020-2025 (K Units)
Figure 37. Middle East & Africa Anti-Infectives Revenue 2020-2025 ($ millions)
Figure 38. Americas Anti-Infectives Sales Market Share by Country in 2025
Figure 39. Americas Anti-Infectives Revenue Market Share by Country (2020-2025)
Figure 40. Americas Anti-Infectives Sales Market Share byType (2020-2025)
Figure 41. Americas Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 42. United States Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Anti-Infectives Sales Market Share by Region in 2025
Figure 47. APAC Anti-Infectives Revenue Market Share by Region (2020-2025)
Figure 48. APAC Anti-Infectives Sales Market Share byType (2020-2025)
Figure 49. APAC Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 50. China Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 54. India Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwan Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Anti-Infectives Sales Market Share by Country in 2025
Figure 58. Europe Anti-Infectives Revenue Market Share by Country (2020-2025)
Figure 59. Europe Anti-Infectives Sales Market Share byType (2020-2025)
Figure 60. Europe Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 61. Germany Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 62.France Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Anti-Infectives Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Anti-Infectives Sales Market Share byType (2020-2025)
Figure 68. Middle East & Africa Anti-Infectives Sales Market Share by Application (2020-2025)
Figure 69. Egypt Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 72.Turkey Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Anti-Infectives Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Anti-Infectives in 2025
Figure 75. Manufacturing Process Analysis of Anti-Infectives
Figure 76. Industry Chain Structure of Anti-Infectives
Figure 77. Channels of Distribution
Figure 78. Global Anti-Infectives Sales MarketForecast by Region (2026-2031)
Figure 79. Global Anti-Infectives Revenue Market ShareForecast by Region (2026-2031)
Figure 80. Global Anti-Infectives Sales Market ShareForecast byType (2026-2031)
Figure 81. Global Anti-Infectives Revenue Market ShareForecast byType (2026-2031)
Figure 82. Global Anti-Infectives Sales Market ShareForecast by Application (2026-2031)
Figure 83. Global Anti-Infectives Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Brucea Javanica Oil Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
136 pages
Global Surface Electrodes Market Growth 2024-2030
US$ 3,660.00
June 2024
120 pages
Global Cervical Spacer Systems Market Growth 2023-2029
US$ 3,660.00
February 2023
92 pages
Global Lab Automation in Clinical Diagnostics Market Growth 2024-2030
US$ 3,660.00
December 2024
100 pages
Global PECAM1 ELISA Kit Market Growth 2024-2030
US$ 3,660.00
December 2024
93 pages
